These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


234 related items for PubMed ID: 15267190

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
    Mane I, Cartel JL, Grosset JH.
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy of single-dose chemotherapy (rifampicin, ofloxacin and minocycline-ROM) in PB leprosy patients with 2 to 5 skin lesions, India: randomised double-blind trial.
    Manickam P, Nagaraju B, Selvaraj V, Balasubramanyam S, Mahalingam VN, Mehendale SM, Pannikar VK, Gupte MD, Team of Study Investigators.
    Indian J Lepr; 2012 Jun; 84(3):195-207. PubMed ID: 23484334
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Single dose multidrug therapy for single lesion paucibacillary leprosy.
    Kars HK.
    Indian J Lepr; 1998 Jun; 70(2):214-5; author reply 219-21. PubMed ID: 9724859
    [No Abstract] [Full Text] [Related]

  • 11. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
    Pai VV, Bulchand HO, Revankar CR, Ganapati R.
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
    [No Abstract] [Full Text] [Related]

  • 12. Single-dose treatment for single lesion leprosy; histopathological observations.
    Shinde A, Khopkar U, Pai VV, Ganapati R.
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):328-30. PubMed ID: 11221099
    [No Abstract] [Full Text] [Related]

  • 13. Single dose multidrug therapy for single lesion paucibacillary leprosy.
    Prasad KN.
    Indian J Lepr; 1998 Sep; 70(2):215-6; author reply 219-21. PubMed ID: 9724860
    [No Abstract] [Full Text] [Related]

  • 14. Single dose multidrug therapy for single lesion paucibacillary leprosy.
    Porichha D.
    Indian J Lepr; 1998 Sep; 70(2):213-4; author reply 219-21. PubMed ID: 9724858
    [No Abstract] [Full Text] [Related]

  • 15. A randomized controlled trial to compare cure and relapse rate of paucibacillary multidrug therapy with monthly rifampicin, ofloxacin, and minocycline among paucibacillary leprosy patients in Agra District, India.
    Kumar A, Girdhar A, Girdhar BK.
    Indian J Dermatol Venereol Leprol; 2015 Sep; 81(4):356-62. PubMed ID: 26144850
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Single-dose rifampicin, oflaxicin and minocycline (ROM) therapy for single leprosy lesions.
    Ramu G.
    Lepr Rev; 1998 Mar; 69(1):78-82. PubMed ID: 9628098
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.